Brand Name(s): Accupril
CAS nš: 85441-61-8
(kwin' a pril)
About Quinapril
This new site is dedicated exclusively to quinapril.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about quinapril, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total quinapril experience!
Why is this medication prescribed?
Quinapril is used for treating high blood pressure and heart failure and for preventing kidney failure due to hypertension and diabetes.
Quinapril belongs in a class of drugs called angiotensin converting enzyme (ACE) inhibitors. ACE inhibitors lower blood pressure by inhibiting the formation of angiotensin II, thereby relaxing the arterial muscles and enlarging the arteries. This increases the flow of blood and oxygen to the heart so that it can pump blood more efficiently. The enlargement of the arteries elsewhere in the body also makes it easier for the heart to pump blood. This is particularly beneficial when there is heart failure.
In the kidneys, this increases blood flow and reduces the filtration pressure in the kidneys.
Latest News
Teva Announces Approval of Generic Accupril Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that, following the expiration...
[more]Amlodipine Added to Quinapril vs Quinapril Alone for the Treatment of Hypertension in Diabetes: The Amlodipine in Diabetes (ANDI) Trial
This randomized, comparative, parallel-group trial investigated strategies of blood pressure...
[more]Clearance of Imidapril, an Angiotensin-Converting Enzyme Inhibitor, During Hemodialysis in Hypertensive Renal Failure Patients: Comparison With Quinapril and Enalapril
The dialyzability of imidaprilat, an active metabolite of the angiotensin-converting enzyme (ACE)...
[more]Auto-intoxication with flecainide and quinapril: ECG-changes, symptoms and treatment
Flecainide acetate is a sodium channel blocker and a class Ic antiarrhythmic agent with potential...
[more]Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy
Background: We evaluated the antithrombotic effects of statins and angiotensin-converting enzyme...
[more]